omni
aaps
FDA Lays Groundwork For Regulating 3D-Printed Drugs
FDA Lays Groundwork For Regulating 3D-Printed Drugs
The pharmaceutical industry tends to attract disruptive technology, as drug and device makers look to make therapeutic advances. But manufacturing - at least for the medicines themselves - has largely stuck to its tried-and-true ways, moving more slowl...
Adalimumab Tops List for Drug Spending, But Biosimilars Impact Impending
Adalimumab Tops List for Drug Spending, But Biosimilars Impact Impending
Adalimumab (Humira, AbbVie) a treatment for rheumatoid arthritis (RA), once again led the pack in drug invoice spending in 2016, with $13.6 billion spent, an excess of $3 billion more than the next highest spend, according to new data from the ...
Fight Over Federal Drug Discount Program Continues in 2018
Fight Over Federal Drug Discount Program Continues in 2018
The battle over the fate of a 25-year-old federal drug discount program could heat up on Capitol Hill this year. At issue is the 340B discount program, which safety-net providers such as hospitals use to obtain often steep discounts on medications from...
Why Identity is Imperative for Pharma Companies
Why Identity is Imperative for Pharma Companies
Pharmaceutical companies are working hard to keep pace with the disruptions brought about by digital technology and a shifting health care landscape.
President Trump's Plan to Lower Drug Prices Spares Pharma Industry
President Trump's Plan to Lower Drug Prices Spares Pharma Industry
President Donald Trump's long-promised plan to bring down drug prices would mostly spare the pharmaceutical industry he previously accused of "getting away with murder." Instead he focuses on private competition and more openness to reduce America's pr...